Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time.
about
Inflammatory bowel disease in Asia: A systematic reviewPredictive factors for a severe clinical course in ulcerative colitis: Results from population-based studiesFactors associated with disease evolution in Greek patients with inflammatory bowel disease.Colon capsule endoscopy: Advantages, limitations and expectations. Which novelties?Characteristics and therapeutic efficacy of sulfasalazine in patients with mildly and moderately active ulcerative colitis.Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis.Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis.Clinical implications of inflammatory bowel disease genetics on phenotype.Ulcerative proctitis: a review of pharmacotherapy and management.Association of age at diagnosis and ulcerative colitis phenotype.The Asia-Pacific consensus on ulcerative colitis.Acute severe ulcerative colitis in children: a systematic review.Recent advances in understanding ulcerative colitis.History of and current issues affecting surgery for pediatric ulcerative colitis.Drug therapies for ulcerative proctitis: systematic review and meta-analysis.Review article: the histological assessment of disease activity in ulcerative colitis.Classification of Paediatric Inflammatory Bowel Disease using Machine LearningThe problem of adherence to therapy in ulcerative colitis and the potential utility of multi-matrix system (MMX) technology.Emerging biologics in inflammatory bowel disease.Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients.Ulcerative colitis extent varies with time but endoscopic appearances may be deceptive.Colorectal cancer surveillance in patients with inflammatory bowel disease: What is new?Oral mesalazine (5-ASA) treatment may protect against proximal extension of mucosal inflammation in ulcerative proctitis.Patients newly diagnosed with ulcerative colitis receive earlier treatment in surgical clinics.New studies on the role of smoking in inflammatory bowel disease: are we not beating a dead horse?Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.European consensus on the histopathology of inflammatory bowel disease.Risk factors and characteristics of extent progression in ulcerative colitis.Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients.Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus.Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and Inflammatory Bowel Disease and their effects on disease behavior: A case-control and meta-analysis studyCD3+CD4+LAP+Foxp3-Regulatory Cells of the Colonic Lamina Propria Limit Disease Extension in Ulcerative Colitis
P2860
Q22242420-805D378B-FB1E-4CF9-86EE-63CD41129989Q26751156-8DCB8326-CFBB-4C54-9DFF-26BE653540FCQ30820594-2780ACE3-A0AF-40E3-8033-7F812FF25579Q34637725-4AD3E6A6-F807-4035-9711-62F4B121D20DQ35010202-3E3A2415-9691-4C8F-8A6B-E36704A30953Q35606275-D35965E9-325E-44CC-8E89-CB4A1084F3BDQ35761403-174E7BCD-223F-4662-90B0-4C4E6F484FF3Q36021426-D315D415-22CD-452A-A022-49DB27623D04Q37111844-4189FB97-6896-46EE-81D1-34C33EF5BB8FQ37414667-EFBD1E74-2801-46D3-B01D-1658D62E55F8Q37725083-39A09FBC-FBF9-4975-8FFE-72A71F8BDC7BQ37774320-BEAFA7C3-2280-4726-9A07-4BA7D08B0140Q37954101-AA437340-2452-43F5-B222-8B2190541903Q38064356-0A82AB8F-6E12-42A3-8C06-51F38011CE68Q38235056-CDCEEB21-BA14-4AB5-BD2B-68271BF82604Q38573248-49E1ED7A-6F05-4E30-A90F-F02F81EE9160Q38762754-264DE3C6-A0A9-48C6-9B2D-66247344AF9EQ38996677-A32129B7-78F9-428B-9DBD-48E783620B91Q39004625-D7641A52-D949-4B02-A4D0-45853F74F90EQ40764556-0C6288FA-2EF1-4238-8C5B-85306FEF081EQ42041071-172C1418-9E6A-4041-A231-A769EB76AC0BQ42082755-4D335B60-5034-4AD0-831D-57242BF7940AQ43566966-4B2F5678-EE8A-463F-986C-2C18662A8F4AQ43596165-6E9D8A5C-29AC-4FFF-9BE3-D4F37EB31C1EQ43651565-DFBA149A-35F1-4B9C-841D-8BE5E11B939EQ43696185-F9BB69A4-45C3-4640-8CA6-8AC6992B1E9FQ46690820-7CA8B3CA-1BDC-4B4B-A6CF-95FCEF9C2571Q46805896-6B66CB19-F1C9-49AE-9426-7DD0E0F26783Q52723572-0336059D-8336-4D1F-82E3-B05AE7F6DDC8Q53632147-7B790864-E7EC-461C-8575-7ED883CC5241Q57436288-699033A0-4E0B-4FEC-B833-BF984E42FD96Q58693554-2135F699-46AD-4CE5-B70F-E8066C6629E1
P2860
Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Change in the extent of colono ...... ulcerative colitis over time.
@en
type
label
Change in the extent of colono ...... ulcerative colitis over time.
@en
prefLabel
Change in the extent of colono ...... ulcerative colitis over time.
@en
P1476
Change in the extent of colono ...... ulcerative colitis over time.
@en
P304
P356
10.1111/J.1572-0241.1999.01145.X
P407
P577
1999-06-01T00:00:00Z